Patent 9402878 was granted and assigned to NovoBiotic Pharmaceuticals on August, 2016 by the United States Patent and Trademark Office.
The present invention relates generally to novel depsipeptides, to methods for the preparation of these novel depsipeptides, to pharmaceutical compositions comprising the novel depsipeptides; and to methods of using the novel depsipeptides to treat or inhibit various disorders.